Objectives The aim of this study was to evaluate very long‐term results after unrestricted everolimus‐eluting bioresorbable scaffolds (BRS) implantation. Background Previous randomized studies mainly included selected patients differing from those seen during daily routine and long‐term data from all‐comers registries are sparse. Methods Consecutive patients undergoing BRS implantation were included in this observational, single center study. Clinical follow‐up was conducted up to 5 years. Endpoint of interest was the composite of target lesion failure (TLF), including target‐vessel myocardial infarction and target lesion revascularization and cardiac death. Furthermore, ARC‐defined scaffold thrombosis (ScT) were assessed. ...
Background: There is still limited data on the very long term clinical outcomes after ABSORB BRS in ...
BACKGROUND: There is still limited data on the very long term clinical outcomes after ABSORB BRS in ...
Background The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safet...
BACKGROUND: Bioresorbable scaffolds (BRS) have been introduced to overcome the limitations of drug-e...
Objectives: To asses mid-term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the tr...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
OBJECTIVES: To asses mid-term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the tr...
BACKGROUND Long-term benefits of coronary stenosis treatment with an everolimus-eluting bioresorb...
Background: Data on procedural and clinical outcomes of the everolimus-eluting bioresorbable vascula...
textabstractAims To compare the long-term safety and efficacy of bioresorbable vascular scaffold (BV...
Abstract Background: Bioresorbable vascular scaffolds (BVS) were developed to improve the long-term...
Introduction Previous midterm follow-up reports after implantation of the Absorb™ everolimus-eluting...
BACKGROUND: Limited data are currently available on the performance of everolimus eluting bioresorba...
BACKGROUND: Most of the current data regarding the use of bioresorbable scaffolds (BRS) come from ev...
AIMS Limited data are currently available on midterm outcomes after implantation of everolimus-el...
Background: There is still limited data on the very long term clinical outcomes after ABSORB BRS in ...
BACKGROUND: There is still limited data on the very long term clinical outcomes after ABSORB BRS in ...
Background The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safet...
BACKGROUND: Bioresorbable scaffolds (BRS) have been introduced to overcome the limitations of drug-e...
Objectives: To asses mid-term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the tr...
Background: Absorb bioresorbable vascular scaffold (BVS)-related events have been reported between 1...
OBJECTIVES: To asses mid-term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the tr...
BACKGROUND Long-term benefits of coronary stenosis treatment with an everolimus-eluting bioresorb...
Background: Data on procedural and clinical outcomes of the everolimus-eluting bioresorbable vascula...
textabstractAims To compare the long-term safety and efficacy of bioresorbable vascular scaffold (BV...
Abstract Background: Bioresorbable vascular scaffolds (BVS) were developed to improve the long-term...
Introduction Previous midterm follow-up reports after implantation of the Absorb™ everolimus-eluting...
BACKGROUND: Limited data are currently available on the performance of everolimus eluting bioresorba...
BACKGROUND: Most of the current data regarding the use of bioresorbable scaffolds (BRS) come from ev...
AIMS Limited data are currently available on midterm outcomes after implantation of everolimus-el...
Background: There is still limited data on the very long term clinical outcomes after ABSORB BRS in ...
BACKGROUND: There is still limited data on the very long term clinical outcomes after ABSORB BRS in ...
Background The Absorb bioresorbable vascular scaffold (BVS) was developed to address long-term safet...